US20020016488A1 - Uv-photoprotective dibenzoylmethane compositions comprising photostabilizing amounts of benzalmalonate silanes - Google Patents

Uv-photoprotective dibenzoylmethane compositions comprising photostabilizing amounts of benzalmalonate silanes Download PDF

Info

Publication number
US20020016488A1
US20020016488A1 US09/332,200 US33220099A US2002016488A1 US 20020016488 A1 US20020016488 A1 US 20020016488A1 US 33220099 A US33220099 A US 33220099A US 2002016488 A1 US2002016488 A1 US 2002016488A1
Authority
US
United States
Prior art keywords
sunscreen
cosmetic composition
radical
dibenzoylmethane
benzalmalonate
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
US09/332,200
Other versions
US6426428B2 (en
Inventor
Serge Forestier
Herve Richard
Delphine Allard
Didier Candau
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to US09/332,200 priority Critical patent/US6426428B2/en
Publication of US20020016488A1 publication Critical patent/US20020016488A1/en
Application granted granted Critical
Publication of US6426428B2 publication Critical patent/US6426428B2/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q17/00Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
    • A61Q17/04Topical preparations for affording protection against sunlight or other radiation; Topical sun tanning preparations
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/35Ketones, e.g. benzophenone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/58Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing atoms other than carbon, hydrogen, halogen, oxygen, nitrogen, sulfur or phosphorus
    • A61K8/585Organosilicon compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/52Stabilizers

Definitions

  • the present invention relates to novel topically applicable UV-photoprotective compositions containing at least one normally photolabile dibenzoylmethane UV-screening compound and, as a photostabilizer therefor, an effective amount of at least one particular benzalmalonate silane.
  • This invention also relates to certain novel processes for the synthesis of said particular benzalmalonate silanes.
  • UV-A irradiation of wavelengths of from 320 to 400 nm, which promotes tanning of the skin, also adversely affects it, especially in the case of a sensitive skin or of a skin which is continuously exposed to solar radiation.
  • the UV-A rays in particular, cause a loss in the elasticity of the skin and the appearance of wrinkles, resulting in premature cutaneous aging.
  • UV-A radiation promotes triggering of the erythematous reaction or amplifies this reaction in certain individuals and can even be the source of phototoxic or photoallergic reactions.
  • more and more individuals seek to control the effect of UV-A rays on their skin. It is thus desirable to also filter out UV-A radiation.
  • one class of UV-A filters of particular interest comprises the dibenzoylmethane compounds, and especially 4-tert-butyl-4′-methoxydibenzoylmethane, which indeed have a great capacity for intrinsic absorption.
  • dibenzoylmethane compounds which are per se well known as active filters in the UV-A region, are described, in particular, in FR-A-2,326,405 and FR-2,440,933, as well as in EP-A-0,114,607; 4-tert-butyl-4′-methoxydibenzoylmethane is also commercially available under the trademark “PARSOL 1789” by GIVAUDAN.
  • the dibenzoylmethane derivatives are compounds which are relatively sensitive to ultraviolet radiation (especially UV-A irradiation), namely, they have an unfortunate tendency to degrade to a more or less rapid extent under the action of such radiation.
  • UV-A irradiation especially UV-A irradiation
  • this substantial lack of photochemical stability of dibenzoylmethane compounds with regard to ultraviolet radiation does not permit constant protection to be guaranteed during prolonged exposure to the sun, such that, in a restrictive fashion, repeated applications at regular and close intervals of time must be carried out by the user to provide an efficacious protection of the skin against UV rays.
  • EP-A-0,709,080 describes combining dibenzoylmethane derivatives with very specific benzalmalonate derivatives, namely, benzalmalonate siloxanes, in order to decrease the photoinstability of said dibenzoylmethane compounds.
  • this ′080 application mandates that the siloxane structure of these compounds is essential to provide satisfactory photostabilization (see page 10, line 22 of EP-A-0,709,080).
  • these benzalmalonate siloxanes are molecules which are bulky and complex to synthesize.
  • the present invention features improving the photostability of at least one photolabile dibenzoylmethane compound with respect to UV-radiation, by intimately combining said dibenzoylmethane compounds with an effective amount of at least one benzalmalonate silane having the following structural formula (I):
  • R 1 , R 2 and R 3 which may be identical or different, are each an optionally halogenated C 1 -C 10 alkyl radical or a phenyl radical
  • R 4 and P 5 which may be identical or different, are each a hydrogen atom, a hydroxyl radical, a C 1 -C 6 alkyl radical, a C 1 -C 6 alkoxy radical, or a trimethylsilyloxy radical
  • R 6 and R 7 which may be identical or different, are each a C 1 -C 8 alkyl radical
  • a is equal to 0 or 1
  • Y is a divalent radical having one of the following formulae (1) to (4):
  • R 8 is a hydrogen atom or a C 1 -C 5 alkyl radical
  • the subject cosmetic and/or dermatological compositions present the advantage of being particularly photostable, even after prolonged exposure to TV-A and UV-B radiation.
  • This radiation can be of natural (sun) or artificial (UV lamp) origin.
  • the benzalmalonate silanes being molecules which are quite easy to synthesize, the compositions according to the invention are likewise readily formulated industrially.
  • the present invention thus features the use of a benzalmalonate silane to enhance the stability with respect to UV rays of a dibenzoylmethane compound contained in a UV-screening cosmetic and/or dermatological composition.
  • the dibenzoylmethane derivatives that are photostabilized according to the present invention are compounds which are per se known to this art and are described in the abovementioned FR-A-2,326,405, FR-A-2,440,933 and EP-A-0,114,607.
  • Particularly exemplary dibenzoylmethane compounds according to the present invention include the following:
  • Another preferred dibenzoylmethane compound according to the present invention is 4-isopropyldibenzoylmethane, a filter marketed under the trademark “EUSOLEX 8020” by MERCK, and having the following structural formula:
  • the dibenzoylmethane derivatives are advantageously present in the stabilized compositions according to the invention in amounts generally ranging from 0.01% to 10% by weight and preferably in amounts ranging from 0.3% to 5 % by weight, with respect to the total weight of the composition.
  • benzalmalonate silanes according to this invention are known compounds which are described, especially, in JP-07/330,779. These have the following structural formula (I):
  • R 1 , R 2 and R 3 which may be identical or different, are each an optionally halogenated C 1 -C 10 alkyl radical or a phenyl radical
  • R 4 and R 5 which may be identical or different, are each a hydrogen atom, a hydroxyl radical, a C 1 -C 6 alkyl radical, a C 1 -C 6 alkoxy radical, or a trimethylsilyloxy radical
  • R 6 and R 7 which may be identical or different, are each a C 1 -C 8 alkyl radical
  • a is equal to 0 or 1
  • Y is a divalent radical having one of the following formulae (1) to (4):
  • R 8 is a hydrogen atom or a C 1 -C 5 alkyl radical
  • the benzalmalonate silanes according to the invention present the advantage of being much more simple to synthesize and to purify than the benzalmalonate siloxanes known to the prior art. Too, the process of the invention is likewise easier to carry out on an industrial scale.
  • silanes of formula (1) above and satisfying at least one, preferably all, of the following conditions are employed:
  • R 1 is methyl
  • R 2 is methyl or ethyl
  • R 3 is methyl
  • Y is a divalent radical of formula (3) or (4) in which R 8 is hydrogen or methyl and p is 1 or 2,
  • R 4 is hydrogen or a methoxy radical
  • R 5 is hydrogen
  • R 6 is methyl or ethyl
  • R 7 is methyl or ethyl
  • silanes according to the present invention are the compounds having the following structural formulae (5), (6) and (7):
  • the present invention features a first process (reaction scheme A) for the preparation of the compounds of formula (I) in which a is 1, comprising, in a first step, reacting an aromatic hydroxybenzaldehyde of formula (8) below with a halogenated silane derivative of formula (9) below. Then, in a second step, the benzaldehyde of formula (10) thus obtained is condensed with a malonic diester of formula (11) below.
  • the aromatic hydroxybenzaldehyde and the halogenated silane derivative are reacted in the presence of a base according to a conventional alkylation reaction, the condensation of the benzaldehyde obtained with the malonic diester being carried out in toluene in the presence of piperidinium acetate as a catalyst (Knoevenagel condensation) according to the following reaction scheme:
  • the present invention also features a second process (reaction scheme B) for the preparation of the compounds of formula (1) in which a is 1, comprising reacting a hydroxybenzalmalonate of formula (12) below with a halogenated silane derivative of formula (9).
  • reaction scheme B for the preparation of the compounds of formula (1) in which a is 1, comprising reacting a hydroxybenzalmalonate of formula (12) below with a halogenated silane derivative of formula (9).
  • Exemplary aromatic benzaldehyde derivatives include 4-hydroxybenzaldehyde or vanillin, which are commercially available products.
  • Exemplary malonic ester derivatives include dimethyl malonate or diethyl malonate, which are also commercially available.
  • An exemplary hydroxybenzalmalonate derivative is dimethyl parahydroxybenzalmalonate marketed by ACROS.
  • an exemplary silane halide derivative is chloropropyltrimethylsilane, marketed by WACKER.
  • an “effective amount” of benzalmalonate silane according to the invention is intended an amount sufficient to provide a notable and significant improvement in the photostability of the dibenzoylmethane derivative(s) contained in the composition.
  • the minimum amount of stabilizing agent to be employed which can vary according to the nature of the cosmetically acceptable support (vehicle, diluent or carrier) reserved for the composition, can be determined without any difficulty by means of a conventional photostability measuring test, such as described in FR-A-2,607,700.
  • the benzalmalonate silanes are generally present in the compositions according to the invention in a content at least equal to 0.5% by weight, with respect to the total weight of the composition. More preferably, this amount ranges from 0.5% to 20% by weight, with respect to the total weight of the composition.
  • the cosmetic and/or dermatological compositions of this invention can, of course, contain one or more hydrophilic or lipophilic complementary screening agents active in the UV-A and/or UV-B (absorbers) ranges.
  • These complementary sunscreens are advantageously selected from among cinnamic derivatives, the salicylic derivatives, the benzylidene camphor derivatives, the benzimidazole derivatives, the triazine derivatives, the benzophenone derivatives, the ⁇ , ⁇ ′-diphenylacrylate derivatives, the p-aminobenzoic acid derivatives, the sunscreen polymers and filtering silicones described in WO-93/04665.
  • Other examples of organic sunscreens are described in EP-A- 487,404.
  • compositions according to the invention can also contain artificial skin bronzing and/or browning agents (self-tanning agents) such as, for example, dihydroxyacetone (DHA).
  • artificial skin bronzing and/or browning agents such as, for example, dihydroxyacetone (DHA).
  • DHA dihydroxyacetone
  • the cosmetic and/or dermatological compositions of this invention can also contain pigments or nanopigments (average size of the primary particles: generally ranging from 5 nm to 100 nm, preferably from 10 and 50 nm) of coated or un-coated metallic oxides such as, for example, nanopigments of titanium dioxide (amorphous or crystallized in rutile and/or anatase form), of iron, of zinc, of zirconium, or of cerium, which are all photoprotective agents per se well known and acting by physical blocking (reflection and/or diffusion) of the UV radiation.
  • Conventional coating agents are, in addition, alumina and/or aluminum stearate.
  • Such nanopigments of metallic oxides, coated or un-coated, are described, in particular, in EP-A-518,772 and EP-A-518,773.
  • compositions of the present invention can additionally comprise conventional cosmetic adjuvants and additives, especially selected from among fatty substances, organic solvents, ionic or non-ionic thickeners, softeners, antioxidants, anti-free radical agents, opacifiers, stabilizers, emollients, silicones, x-hydroxy acids, anti-foaming agents, hydrating agents, vitamins, perfumes, preservatives, surfactants, fillers, sequestrants, polymers, propellants, insect repellents, basifying or acidifying agents, colorants, dyes, pigments, or any other ingredients usually used in the cosmetic and/or dermatological field, in particular for the formulation of sunscreen compositions as emulsions.
  • conventional cosmetic adjuvants and additives especially selected from among fatty substances, organic solvents, ionic or non-ionic thickeners, softeners, antioxidants, anti-free radical agents, opacifiers, stabilizers, emollients, silicones, x-hydroxy acids, anti-f
  • the fatty substances can be an oil or a wax or mixtures thereof.
  • oil is intended a compound which is liquid at ambient temperature.
  • wax is intended a solid or substantially solid compound at ambient temperature, whose melting point is generally greater than 35° C.
  • oils include mineral oils (vaseline); vegetable oils (sweet almond oil, macadamia oil, blackcurrant seed oil, jojoba oil); synthetic oils such as perhydrosqualene, alcohols, fatty acids or esters (such as benzoates of C 12 -C 15 alcohols marketed under the trademark “Finsolv TN” by Finetex, octyl palmitate, isopropyl lanolate, trigylcerides including those of capric/caprylic acids), oxyethylene or oxypropylene fatty esters and ethers; silicone oils (cyclomethicone, polydimethylsiloxanes or PDMS) or fluorinated oils, polyalkylenes.
  • mineral oils vasine
  • vegetable oils sweet almond oil, macadamia oil, blackcurrant seed oil, jojoba oil
  • synthetic oils such as perhydrosqualene, alcohols, fatty acids or esters (such as benzoates of C 12 -C 15 alcohols marketed under the trademark
  • Exemplary waxy compounds include paraffin, carnauba wax, beeswax, hydrogenated castor oil.
  • Exemplary organic solvents include the lower alcohols and polyols.
  • exemplary thickeners are crosslinked polyacrylic acids, guar gums and modified or unmodified celluloses such as hydroxypropylated guar gum, methylhydroxyethylcellulose and hydroxypropylmethylcellulose.
  • compositions according to the invention can be formulated according to the techniques well know to this art, in particular those intended for the preparation of emulsions of oil-in-water or water-in-oil type.
  • compositions are advantageously formulated in simple or complex emulsion form (W/O, O/W, O/W/O or W/O/W) such as a cream, a milk, or in the form of a gel or of a cream gel, a powder, a solid stick and can optionally be presented as an aerosol and be present in the form of foam or of spray.
  • W/O, O/W, O/W/O or W/O/W simple or complex emulsion form
  • compositions according to the invention are formulated as oil-in-water emulsions.
  • the aqueous phase of this can comprise a non-ionic vesicle dispersion prepared according to known techniques (Bangham, Standish and Watkins, J. Mol. Biol., 13, 238 (1965), FR-2,315,991 and FR-2,416,008).
  • compositions of the invention are useful photoprotective compositions for the human epidermis or hair against ultraviolet radiation, as sunscreen compositions or as a makeup product.
  • the cosmetic compositions according to the invention are used for the protection of the human epidermis against UV rays, or as sunscreen compositions, they can be formulated in suspension or dispersion form in solvents or fatty substances, in non-ionic vesicle dispersion form, or, alternatively, in emulsion form, preferably of oil-in-water type, such as a cream or a milk, a lotion, gel, cream gel, ointment, solid tube, stick, aerosol mousse or spray.
  • oil-in-water type such as a cream or a milk, a lotion, gel, cream gel, ointment, solid tube, stick, aerosol mousse or spray.
  • the cosmetic compositions according to the invention are used for the protection of the hair
  • same can be formulated as a shampoo, lotion, gel, emulsion, non-ionic vesicle dispersion, hair lacquer and can constitute, for example, a composition for rinsing, to be applied before or after shampooing, before or after coloring or bleaching, before, during or after permanent waving or straightening, a styling or treating lotion or gel, a lotion or a gel for blowdrying or hairsetting, a permanent wave or a straightening, coloring or bleaching composition for the hair.
  • compositions are used as makeup products for the eyelashes, eyebrows or the skin, such as a cream for the treatment of the epidermis, foundation cream, lipstick, eyeshadow, blusher, mascara or eyeliner, same may be formulated in anhydrous or aqueous, solid or pasty form, such as oil-in-water or water-in-oil emulsions, non-ionic vesicle dispersions, or, alternatively, suspensions.
  • the sunscreen formulations in accordance with the invention are advantageously formulated with a support of oil-in-water emulsion type
  • the aqueous phase (especially comprising the hydrophilic sunscreens) generally constitutes from 50% to 95% by weight, preferably from 70% to 90% by weight, with respect to the total weight of the formulation
  • the oily phase (especially comprising the lipophilic sunscreens) from 5% to 50% by weight, preferably from 10% to 30% by weight, with respect to the total weight of the formulation
  • the (co)emulsifier(s) from 0.5% to 20% by weight, preferably from 2% to 10% by weight, with respect to the total weight of the formulation.

Abstract

Topically applicable, stable, UV-photoprotective cosmetic/dermatological compositions well suited for the photoprotection of human skin and/or hair against the damaging effects of TV-A and UV-B irradiation, comprise (a) an effective UV-photoprotecting amount of at least one dibenzoylmethane UV-sunscreen compound and (b) an effective dibenzoylmethane compound (a) photostabilizing amount of at least one benzalmalonate silane having the structural formula (I):
Figure US20020016488A1-20020207-C00001

Description

    CROSS-REFERENCE TO PRIORITY APPLICATION
  • This application claims priority under 35 U.S.C. §119 of FR-97/02759, filed Mar. 7, 1997, hereby expressly incorporated by reference.[0001]
  • BACKGROUND OF THE INVENTION
  • 1. Technical Field of the Invention [0002]
  • The present invention relates to novel topically applicable UV-photoprotective compositions containing at least one normally photolabile dibenzoylmethane UV-screening compound and, as a photostabilizer therefor, an effective amount of at least one particular benzalmalonate silane. [0003]
  • This invention also relates to certain novel processes for the synthesis of said particular benzalmalonate silanes. [0004]
  • 2. Description of the Prior Art [0005]
  • It is known to this art that light radiation of wavelengths ranging from 280 nm to 400 nm promote tanning of the human epidermis, and that radiation of wavelengths more particularly ranging from 280 to 320 nm, i.e., UV-B irradiation, causes erythemas and skin burns which are detrimental to the development of natural bronzing and tanning. For these reasons, as well as for aesthetic reasons, there is a constant demand for means to control this natural bronzing and thus control the coloration of the skin; it is thus advisable to filter such UV-B radiation from the skin. [0006]
  • It is also known to this art that UV-A irradiation, of wavelengths of from 320 to 400 nm, which promotes tanning of the skin, also adversely affects it, especially in the case of a sensitive skin or of a skin which is continuously exposed to solar radiation. The UV-A rays, in particular, cause a loss in the elasticity of the skin and the appearance of wrinkles, resulting in premature cutaneous aging. UV-A radiation promotes triggering of the erythematous reaction or amplifies this reaction in certain individuals and can even be the source of phototoxic or photoallergic reactions. Thus, for aesthetic and cosmetic reasons such as the preservation of the natural elasticity of the skin, for example, more and more individuals seek to control the effect of UV-A rays on their skin. It is thus desirable to also filter out UV-A radiation. [0007]
  • In this respect, one class of UV-A filters of particular interest comprises the dibenzoylmethane compounds, and especially 4-tert-butyl-4′-methoxydibenzoylmethane, which indeed have a great capacity for intrinsic absorption. These dibenzoylmethane compounds, which are per se well known as active filters in the UV-A region, are described, in particular, in FR-A-2,326,405 and FR-2,440,933, as well as in EP-A-0,114,607; 4-tert-butyl-4′-methoxydibenzoylmethane is also commercially available under the trademark “PARSOL 1789” by GIVAUDAN. [0008]
  • Unfortunately, the dibenzoylmethane derivatives are compounds which are relatively sensitive to ultraviolet radiation (especially UV-A irradiation), namely, they have an unfortunate tendency to degrade to a more or less rapid extent under the action of such radiation. Thus, this substantial lack of photochemical stability of dibenzoylmethane compounds with regard to ultraviolet radiation which by their very nature they are intended to be subjected, does not permit constant protection to be guaranteed during prolonged exposure to the sun, such that, in a restrictive fashion, repeated applications at regular and close intervals of time must be carried out by the user to provide an efficacious protection of the skin against UV rays. [0009]
  • The photostabilization of dibenzoylmethane compounds with respect to UV radiation remains a problem which to date has not satisfactorily been resolved. [0010]
  • Thus, EP-A-0,709,080 describes combining dibenzoylmethane derivatives with very specific benzalmalonate derivatives, namely, benzalmalonate siloxanes, in order to decrease the photoinstability of said dibenzoylmethane compounds. In particular, this ′080 application mandates that the siloxane structure of these compounds is essential to provide satisfactory photostabilization (see page 10, line 22 of EP-A-0,709,080). However, these benzalmalonate siloxanes are molecules which are bulky and complex to synthesize. [0011]
  • SUMMARY OF THE INVENTION
  • It has now unexpectedly and surprisingly been determined that combining the dibenzoylmethane compounds indicated above with a photostabilizing effective amount, not of a benzalmalonate siloxane, but of a benzalmalonate silane, markedly enhances the photochemical stability (or photostability) of these same dibenzoylmethane compounds. [0012]
  • It has also been determined that certain novel processes for the preparation of various of these benzalmalonate silanes present the advantage of being much more easy to carry out than the hydrosilylation process described in the prior art, for example, in JP-07/330,779. [0013]
  • Thus, the present invention features improving the photostability of at least one photolabile dibenzoylmethane compound with respect to UV-radiation, by intimately combining said dibenzoylmethane compounds with an effective amount of at least one benzalmalonate silane having the following structural formula (I): [0014]
    Figure US20020016488A1-20020207-C00002
  • in which R[0015] 1, R2 and R3, which may be identical or different, are each an optionally halogenated C1-C10 alkyl radical or a phenyl radical; R4 and P5, which may be identical or different, are each a hydrogen atom, a hydroxyl radical, a C1-C6 alkyl radical, a C1-C6 alkoxy radical, or a trimethylsilyloxy radical; R6 and R7, which may be identical or different, are each a C1-C8 alkyl radical; a is equal to 0 or 1; and Y is a divalent radical having one of the following formulae (1) to (4):
    Figure US20020016488A1-20020207-C00003
  • wherein R[0016] 8 is a hydrogen atom or a C1-C5 alkyl radical, and p is an integer ranging from 1 to 10, inclusive, with the proviso that the group -Y- (O)a- and the two groups R4 and R5 are variously bonded to the aromatic ring member in the para-position and in the two meta-positions with respect to the radical -CH=C-[(CO2R6)](CO2R7).
  • DETAILED DESCRIPTION OF BEST MODE AND SPECIFIC/PREFERRED EMBODIMENTS OF THE INVENTION
  • More particularly according to the present invention, the subject cosmetic and/or dermatological compositions present the advantage of being particularly photostable, even after prolonged exposure to TV-A and UV-B radiation. This radiation can be of natural (sun) or artificial (UV lamp) origin. In addition, as described below, the benzalmalonate silanes being molecules which are quite easy to synthesize, the compositions according to the invention are likewise readily formulated industrially. [0017]
  • The present invention thus features the use of a benzalmalonate silane to enhance the stability with respect to UV rays of a dibenzoylmethane compound contained in a UV-screening cosmetic and/or dermatological composition. [0018]
  • As indicated above, the dibenzoylmethane derivatives that are photostabilized according to the present invention are compounds which are per se known to this art and are described in the abovementioned FR-A-2,326,405, FR-A-2,440,933 and EP-A-0,114,607. [0019]
  • According to the present invention, it is of course envisioned to employ one or more dibenzoylmethane compounds. [0020]
  • Particularly exemplary dibenzoylmethane compounds according to the present invention include the following: [0021]
  • 2-methyldibenzoylmethane; [0022]
  • 4-methyldibenzoylmethane; [0023]
  • 4-isopropyldibenzoylmethane; [0024]
  • 4-tert-butyldibenzoylmethane; [0025]
  • 2,4-dimethyldibenzoylmethane; [0026]
  • 2,5-dimethyldibenzoylmethane; [0027]
  • 4,4-diisopropyldibenzoylmethane; [0028]
  • 4-tert-butyl-4′-methoxydibenzoylmethane; [0029]
  • 2-methyl-5-isopropyl-4′-methoxydibenzoylmethane; [0030]
  • 2-methyl-5-tert-butyl-4′-methoxydibenzoylmethane; [0031]
  • 2,4-dimethyl-4′-methoxydibenzoylmethane; [0032]
  • 2,6-dimethyl-4-tert-butyl-4′-methoxydibenzoylmethane; [0033]
  • 4,4′-dimethoxydibenzoylmethane. [0034]
  • Among the dibenzoylmethane compounds indicated above, preferred is 4-tert-butyl-4′-methoxydibenzoylmethane, especially that commercially available under the trademark “PARSOL 1789” by GIVAUDAN, this filter thus having the following structural formula: [0035]
    Figure US20020016488A1-20020207-C00004
  • Another preferred dibenzoylmethane compound according to the present invention is 4-isopropyldibenzoylmethane, a filter marketed under the trademark “EUSOLEX 8020” by MERCK, and having the following structural formula: [0036]
    Figure US20020016488A1-20020207-C00005
  • The dibenzoylmethane derivatives are advantageously present in the stabilized compositions according to the invention in amounts generally ranging from 0.01% to 10% by weight and preferably in amounts ranging from 0.3% to 5 % by weight, with respect to the total weight of the composition. [0037]
  • As indicated above, the benzalmalonate silanes according to this invention are known compounds which are described, especially, in JP-07/330,779. These have the following structural formula (I): [0038]
    Figure US20020016488A1-20020207-C00006
  • in which R[0039] 1, R2 and R3, which may be identical or different, are each an optionally halogenated C1-C10 alkyl radical or a phenyl radical; R4 and R5, which may be identical or different, are each a hydrogen atom, a hydroxyl radical, a C1-C6 alkyl radical, a C1-C6 alkoxy radical, or a trimethylsilyloxy radical; R6 and R7, which may be identical or different, are each a C1-C8 alkyl radical; a is equal to 0 or 1; and Y is a divalent radical having one of the following formulae (1) to (4):
    Figure US20020016488A1-20020207-C00007
  • wherein R[0040] 8 is a hydrogen atom or a C1-C5 alkyl radical, and p is an integer ranging from 1 to 10, inclusive, with the proviso that the group -Y- (O)a and the two groups R4 and R5, are variously bonded to the aromatic ring member in the para-position and in the two meta-positions with respect to the radical -CH=C-[(CO2R6)](CO2R7).
  • The benzalmalonate silanes according to the invention, as will later be seen, present the advantage of being much more simple to synthesize and to purify than the benzalmalonate siloxanes known to the prior art. Too, the process of the invention is likewise easier to carry out on an industrial scale. [0041]
  • In a preferred embodiment of the invention, the silanes of formula (1) above and satisfying at least one, preferably all, of the following conditions are employed: [0042]
  • R[0043] 1 is methyl,
  • R[0044] 2 is methyl or ethyl,
  • R[0045] 3 is methyl,
  • Y is a divalent radical of formula (3) or (4) in which R[0046] 8 is hydrogen or methyl and p is 1 or 2,
  • a is 1, [0047]
  • R[0048] 4 is hydrogen or a methoxy radical,
  • R[0049] 5 is hydrogen,
  • R[0050] 6 is methyl or ethyl,
  • R[0051] 7 is methyl or ethyl,
  • the -Y- (O)[0052] a group is bonded to the aromatic ring member in the para-position with respect to the -CH=C-[(CO2R6)](CO2R7) radical.
  • Particularly suitable silanes according to the present invention are the compounds having the following structural formulae (5), (6) and (7): [0053]
    Figure US20020016488A1-20020207-C00008
  • To prepare the compounds of formula (I) in which a=0, a hydrosilylation reaction is carried out between the corresponding unsaturated derivative and the corresponding silane such as is described in JP-07/330,779. [0054]
  • The present invention features a first process (reaction scheme A) for the preparation of the compounds of formula (I) in which a is 1, comprising, in a first step, reacting an aromatic hydroxybenzaldehyde of formula (8) below with a halogenated silane derivative of formula (9) below. Then, in a second step, the benzaldehyde of formula (10) thus obtained is condensed with a malonic diester of formula (11) below. Preferably, the aromatic hydroxybenzaldehyde and the halogenated silane derivative are reacted in the presence of a base according to a conventional alkylation reaction, the condensation of the benzaldehyde obtained with the malonic diester being carried out in toluene in the presence of piperidinium acetate as a catalyst (Knoevenagel condensation) according to the following reaction scheme: [0055]
    Figure US20020016488A1-20020207-C00009
  • in which Y, R[0056] 1, R2, R3, R4, R5, R6 and R7 are as defined above for formula (1) and Hal is a halogen, preferably chlorine.
  • The present invention also features a second process (reaction scheme B) for the preparation of the compounds of formula (1) in which a is 1, comprising reacting a hydroxybenzalmalonate of formula (12) below with a halogenated silane derivative of formula (9). Preferably, the hydroxybenzalmalonate and the halogenated silane derivative are reacted in the presence of a base according to a conventional alkylation reaction according to the following scheme: [0057]
    Figure US20020016488A1-20020207-C00010
  • in which Y, R[0058] 1, R2, R3, R4, R5, R6 and R7 are as defined in formula (I) and Hal is a halogen, preferably chlorine.
  • The above syntheses present the advantage of being easier to carry out than hydrosilylation reactions. [0059]
  • Exemplary aromatic benzaldehyde derivatives include 4-hydroxybenzaldehyde or vanillin, which are commercially available products. [0060]
  • Exemplary malonic ester derivatives include dimethyl malonate or diethyl malonate, which are also commercially available. [0061]
  • An exemplary hydroxybenzalmalonate derivative is dimethyl parahydroxybenzalmalonate marketed by ACROS. [0062]
  • And an exemplary silane halide derivative is chloropropyltrimethylsilane, marketed by WACKER. [0063]
  • By an “effective amount” of benzalmalonate silane according to the invention is intended an amount sufficient to provide a notable and significant improvement in the photostability of the dibenzoylmethane derivative(s) contained in the composition. The minimum amount of stabilizing agent to be employed, which can vary according to the nature of the cosmetically acceptable support (vehicle, diluent or carrier) reserved for the composition, can be determined without any difficulty by means of a conventional photostability measuring test, such as described in FR-A-2,607,700. [0064]
  • The benzalmalonate silanes are generally present in the compositions according to the invention in a content at least equal to 0.5% by weight, with respect to the total weight of the composition. More preferably, this amount ranges from 0.5% to 20% by weight, with respect to the total weight of the composition. [0065]
  • The cosmetic and/or dermatological compositions of this invention can, of course, contain one or more hydrophilic or lipophilic complementary screening agents active in the UV-A and/or UV-B (absorbers) ranges. These complementary sunscreens are advantageously selected from among cinnamic derivatives, the salicylic derivatives, the benzylidene camphor derivatives, the benzimidazole derivatives, the triazine derivatives, the benzophenone derivatives, the β, β′-diphenylacrylate derivatives, the p-aminobenzoic acid derivatives, the sunscreen polymers and filtering silicones described in WO-93/04665. Other examples of organic sunscreens are described in EP-A- 487,404. [0066]
  • The compositions according to the invention can also contain artificial skin bronzing and/or browning agents (self-tanning agents) such as, for example, dihydroxyacetone (DHA). [0067]
  • The cosmetic and/or dermatological compositions of this invention can also contain pigments or nanopigments (average size of the primary particles: generally ranging from 5 nm to 100 nm, preferably from 10 and 50 nm) of coated or un-coated metallic oxides such as, for example, nanopigments of titanium dioxide (amorphous or crystallized in rutile and/or anatase form), of iron, of zinc, of zirconium, or of cerium, which are all photoprotective agents per se well known and acting by physical blocking (reflection and/or diffusion) of the UV radiation. Conventional coating agents are, in addition, alumina and/or aluminum stearate. Such nanopigments of metallic oxides, coated or un-coated, are described, in particular, in EP-A-518,772 and EP-A-518,773. [0068]
  • The compositions of the present invention can additionally comprise conventional cosmetic adjuvants and additives, especially selected from among fatty substances, organic solvents, ionic or non-ionic thickeners, softeners, antioxidants, anti-free radical agents, opacifiers, stabilizers, emollients, silicones, x-hydroxy acids, anti-foaming agents, hydrating agents, vitamins, perfumes, preservatives, surfactants, fillers, sequestrants, polymers, propellants, insect repellents, basifying or acidifying agents, colorants, dyes, pigments, or any other ingredients usually used in the cosmetic and/or dermatological field, in particular for the formulation of sunscreen compositions as emulsions. [0069]
  • The fatty substances can be an oil or a wax or mixtures thereof. By “oil” is intended a compound which is liquid at ambient temperature. By “wax” is intended a solid or substantially solid compound at ambient temperature, whose melting point is generally greater than 35° C. [0070]
  • Exemplary oils include mineral oils (vaseline); vegetable oils (sweet almond oil, macadamia oil, blackcurrant seed oil, jojoba oil); synthetic oils such as perhydrosqualene, alcohols, fatty acids or esters (such as benzoates of C[0071] 12-C15 alcohols marketed under the trademark “Finsolv TN” by Finetex, octyl palmitate, isopropyl lanolate, trigylcerides including those of capric/caprylic acids), oxyethylene or oxypropylene fatty esters and ethers; silicone oils (cyclomethicone, polydimethylsiloxanes or PDMS) or fluorinated oils, polyalkylenes.
  • Exemplary waxy compounds include paraffin, carnauba wax, beeswax, hydrogenated castor oil. [0072]
  • Exemplary organic solvents include the lower alcohols and polyols. [0073]
  • And exemplary thickeners are crosslinked polyacrylic acids, guar gums and modified or unmodified celluloses such as hydroxypropylated guar gum, methylhydroxyethylcellulose and hydroxypropylmethylcellulose. [0074]
  • It will of course be appreciated that one skilled in this art will take care to select the possible complementary compound(s) indicated above (in particular the complementary sunscreens and/or the amounts thereof such that the advantageous properties intrinsically associated with the compositions of the invention will not, or will not substantially be, altered by the additions envisioned. [0075]
  • The compositions according to the invention can be formulated according to the techniques well know to this art, in particular those intended for the preparation of emulsions of oil-in-water or water-in-oil type. [0076]
  • The subject compositions are advantageously formulated in simple or complex emulsion form (W/O, O/W, O/W/O or W/O/W) such as a cream, a milk, or in the form of a gel or of a cream gel, a powder, a solid stick and can optionally be presented as an aerosol and be present in the form of foam or of spray. [0077]
  • Preferably, the compositions according to the invention are formulated as oil-in-water emulsions. [0078]
  • When an emulsion is concerned, the aqueous phase of this can comprise a non-ionic vesicle dispersion prepared according to known techniques (Bangham, Standish and Watkins, [0079] J. Mol. Biol., 13, 238 (1965), FR-2,315,991 and FR-2,416,008).
  • The cosmetic and/or dermatological compositions of the invention are useful photoprotective compositions for the human epidermis or hair against ultraviolet radiation, as sunscreen compositions or as a makeup product. [0080]
  • When the cosmetic compositions according to the invention are used for the protection of the human epidermis against UV rays, or as sunscreen compositions, they can be formulated in suspension or dispersion form in solvents or fatty substances, in non-ionic vesicle dispersion form, or, alternatively, in emulsion form, preferably of oil-in-water type, such as a cream or a milk, a lotion, gel, cream gel, ointment, solid tube, stick, aerosol mousse or spray. [0081]
  • When the cosmetic compositions according to the invention are used for the protection of the hair, same can be formulated as a shampoo, lotion, gel, emulsion, non-ionic vesicle dispersion, hair lacquer and can constitute, for example, a composition for rinsing, to be applied before or after shampooing, before or after coloring or bleaching, before, during or after permanent waving or straightening, a styling or treating lotion or gel, a lotion or a gel for blowdrying or hairsetting, a permanent wave or a straightening, coloring or bleaching composition for the hair. [0082]
  • When the compositions are used as makeup products for the eyelashes, eyebrows or the skin, such as a cream for the treatment of the epidermis, foundation cream, lipstick, eyeshadow, blusher, mascara or eyeliner, same may be formulated in anhydrous or aqueous, solid or pasty form, such as oil-in-water or water-in-oil emulsions, non-ionic vesicle dispersions, or, alternatively, suspensions. [0083]
  • The sunscreen formulations in accordance with the invention are advantageously formulated with a support of oil-in-water emulsion type, the aqueous phase (especially comprising the hydrophilic sunscreens) generally constitutes from 50% to 95% by weight, preferably from 70% to 90% by weight, with respect to the total weight of the formulation, the oily phase (especially comprising the lipophilic sunscreens) from 5% to 50% by weight, preferably from 10% to 30% by weight, with respect to the total weight of the formulation, and the (co)emulsifier(s) from 0.5% to 20% by weight, preferably from 2% to 10% by weight, with respect to the total weight of the formulation. [0084]
  • In order to further illustrate the present invention and the advantages thereof, the following specific examples are given, it being understood that same are intended only as illustrative and in nowise limitative. [0085]
  • EXAMPLE 1
  • [0086]
    Figure US20020016488A1-20020207-C00011
  • (a) First Step [0087]
  • Preparation of 3-methoxy-4(3-trimethyl-silanylpropyloxy)benzaldehyde [0088]
  • 3-Chloropropyltrimethylsilane (33.14 g, 0.22 mol) was added dropwise over the course of 20 minutes into a mixture of vanillin (30.4 g, 0.2 mol) and potassium carbonate (30.4 g, 0.22 mol) in 150 ml of dry dimethylformamide (DMF) heated to 50° C. under nitrogen. The mixture was maintained for 4 hours at 95°-110° C. The reaction mixture was cooled and poured into ice water. The aqueous phase was extracted 3 times with dichloromethane. The organic phases were dried over sodium sulfate and concentrated in vacuo. After distillation in vacuo (0.04 mm Hg), 47.5 g (yield: 89%) of 3-methoxy4-(3-trimethylsilanylpropyloxy)benzaldehyde were obtained in the form of a slightly pink oil distilling at 112°- 114° C. and employed as such in the following step (b). [0089]
  • (b) Second Step
  • Preparation of dimethyl 2-[3-methoxy-4-(3-trimethylsilanylpropyloxy)benzylidene]malonate: [0090]
  • A mixture of the compound prepared in step (a) (13.3 g, 0.05 mol) and of dimethyl malonate (7.93 g, 0.06 mol) in 20 ml of toluene was heated to reflux for 3 hours in the presence of 0.5 ml of piperidine and 0.3 ml of acetic acid. The reaction mixture was cooled and poured into water and then extracted with diisopropyl ether. The organic phase was dried over sodium sulfate and concentrated. After crystallization in a 90:10 by volume methanol/water mixture, 15 g (yield: 79%) of the compound having the following characteristics were obtained: [0091]
    (i) white powder
    (ii) m.p.: 51°-52° C.
    (iii) UV (Ethanol) λmax = 331 nm, εmax = 20,300
  • [0092]
    Elemental analysis for C19H28O6Si
    theory: C: 59.97 H: 7.42 Si: 7.38
    found: C: 59.80 H: 9.35 Si: 7.30
  • EXAMPLE 2
  • [0093]
    Figure US20020016488A1-20020207-C00012
  • 3-Chloropropyltrimethylsilane (16.57 g, 0.11 mol) was added dropwise over the course of 10 minutes into a mixture of diethyl 4-hydroxybenzalmalonate (15.18 g, 0.11 mol) and potassium carbonate (15.18 g, 0.11 mol) in 100 ml of dry DMF heated to 80° C. under nitrogen. The mixture was maintained for 3 hours, 30 minutes, at 120°-130° C. The reaction mixture was then cooled and poured into ice water. The aqueous phase was extracted 2 times with dichloromethane. The organic phases were washed with water and then dried over sodium sulfate and concentrated in vacuo. After crystallization in methanol, 31.6 g (yield: 76%) of the compound having the following characteristics were obtained: [0094]
    (i) white powder
    (ii) m.p.: 34°-35° C.
    (iii) UV (Ethanol) λmax = 314 nm, εmax = 26,400
  • [0095]
    Elemental analysis for C20H30O5Si
    theory C: 63.46 H: 7.99 Si: 7.42
    found C: 63.31 H: 7.90 Si: 7.50
  • Thus, it has been determined that the benzalmalonate silane obtained above stabilized 4tert-butyl-4′-methoxydibenzoylmethane with respect to ultraviolet radiation in such manner that was at least as efficacious as the benzalmalonate siloxanes described in EP-A-0,709,080. [0096]
  • While the invention has been described in terms of various preferred embodiments, the skilled artisan will appreciate that various modifications, substitutions, omissions, and changes may be made without departing from the spirit thereof. Accordingly, it is intended that the scope of the present invention be limited solely by the scope of the following claims, including equivalents thereof. [0097]

Claims (22)

What is claimed is:
1. A topically applicable sunscreen/cosmetic composition suited for the UV-photoprotection of human skin and/or hair, comprising (a) an effective UV-photoprotecting amount of at least one dibenzoylmethane UV-sunscreen compound and (b) an effective dibenzoylmethane compound (a) photostabilizing amount of at least one benzalmalonate silane having the structural formula (I):
Figure US20020016488A1-20020207-C00013
in which R1, R2 and R3, which may be identical or different, are each an optionally halogenated C1-C10 alkyl radical or a phenyl radical; R4 and R5, which may be identical or different, are each a hydrogen atom, a hydroxyl group, a C1-C6 alkyl radical, a C1-C6 alkoxy radical, or a trimethylsilyloxy radical; R6 and R7, which may be identical or different, are each a C1-C8 alkyl radical; a is equal to 0 or 1; and Y is a divalent radical having one of the following formulae (1) to (4):
Figure US20020016488A1-20020207-C00014
wherein R1 is a hydrogen atom or a C1-C5 alkyl radical, and p is an integer ranging from 1 to 10, inclusive, with the proviso that the group -Y- (O)a- and the two radicals R4 and R5 are variously bonded to the aromatic ring member in the para-position and in the two meta-positions with respect to the radical -CH=C-[(CO2R6)](CO2R7).
2. The sunscreen/cosmetic composition as defined by claim 1, formulated with a topically applicable, cosmetically/dermatologically acceptable vehicle, diluent or carrier therefor.
3. The sunscreen/cosmetic composition as defined by claim 1, wherein formula (I) at least one of the following conditions is satisfied:
R1 is methyl;
R2 is methyl or ethyl;
R3 is methyl;
Y is a divalent radical of formula (3) or (4) in which R8 is hydrogen or methyl and p is 1 or 2;
a is 1;
R4 is hydrogen or a methoxy radical;
R5 is hydrogen;
R6 is methyl or ethyl;
R7 is methyl or ethyl; and/or
the -Y- (O)a- group is bonded to the aromatic ring member in the para-position with respect to the -CH=C-[(CO2R6)](CO2R7) radical.
4. The sunscreen/cosmetic composition as defined by claim 1, said at least one benzalmalonate silane (I) having one of the following formulae (5), (6) or (7):
Figure US20020016488A1-20020207-C00015
5. The sunscreen/cosmetic composition as defined by claim 1, said at least one dibenzoylmethane compound comprising 2-methyldibenzoylmethane, 4-methyldibenzoylmethane, 4-isopropyldibenzoylmethane, 4-tert-butyldibenzoylmethane, 2,4-dimethyldibenzoylmethane, 2,5-dimethyldibenzoylmethane, 4,4′-diisopropyldibenzoylmethane, 4-tert-butyl-4′-methoxydibenzoylmethane, 2-methyl-5-isopropyl-4′-methoxydibenzoylmethane, 2-methyl-5-tert-butyl-4′-methoxydibenzoylmethane, 2,4-dimethyl-4′-methoxydibenzoylmethane, 2,6-dimethyl-4tert-butyl-4′-methoxy-dibenzoylmethane, and/or 4,4′-dimethoxydibenzoylmethane.
6. The sunscreen/cosmetic composition as defined by claim 5, said at least one dibenzoylmethane compound comprising 4-tert-butyl-4′-methoxydibenzoylmethane.
7. The sunscreen/cosmetic composition as defined by claim 5, said at least one dibenzoylmethane compound comprising 4-isopropyldibenzoylmethane.
8. The sunscreen/cosmetic composition as defined by claim 1, comprising from 0.5% to 20% by weight of said at least one benzalmalonate silane (I).
9. The sunscreen/cosmetic composition as defined by claim 1, further comprising at least one additional hydrophilic or lipophilic organic UV-A and/or UV-B sunscreen.
10. The sunscreen/cosmetic composition as defined by claim 1, further comprising at least one active agent for the artificial tanning and/or browning of human skin.
11. The sunscreen/cosmetic composition as defined by claim 1, further comprising at least one additive or adjuvant which comprises a fat, organic solvent, ionic or nonionic thickening agent, softener, antioxidant, anti-free radical antioxidant, opacifying agent, stabilizing agent, emollient, silicone, x-hydroxy acid, anti-foaming agent, hydrating agent, vitamin, fragrance, preservative, surfactant, filler, sequestering agent, polymer, propellant, insect repellent, basifying or acidifying agent, dye, colorant, pigment, nanopigment, or mixture thereof.
12. The sunscreen/cosmetic composition as defined by claim 1, comprising a nonionic vesicle dispersion, emulsion, cream, milk, gel, cream gel, ointment, suspension, dispersion, powder, solid, stick, foam or spray.
13. The sunscreen/cosmetic composition as defined by claim 1, comprising a makeup.
14. The sunscreen/cosmetic composition as defined by claim 1, comprising an anhydrous or aqueous solid or paste, emulsion, suspension, or dispersion.
15. The sunscreen/cosmetic composition as defined by claim 1, comprising a shampoo, lotion, gel, emulsion, nonionic vesicle dispersion, hair lacquer, or rinse.
16. The sunscreen/cosmetic composition as defined by claim 1, comprising a skin cream, foundation, face powder, lipstick, mascara, eyeliner, hair gel, hair lotion, or shampoo.
17. A method for protecting human skin and/or hair against the deleterious effects of ultraviolet irradiation, comprising topically applying thereto an effective amount of the sunscreen/cosmetic composition as defined by claim 1.
18. A method for protecting human skin and/or hair against the deleterious effects of solar radiation, comprising topically applying thereto an effective amount of the sunscreen/cosmetic composition as defined by claim 1.
19. A process for the preparation of a benzalmalonate silane (I) as defined in claim 1 and wherein a is 1, comprising reacting an aromatic hydroxybenzaldehyde having the structural formula (8):
Figure US20020016488A1-20020207-C00016
with a halogenated silane having the formula (9):
Hal-Y-SiR1R2R3 (9)
in which Hal is a halogen atom, and then condensing the benzaldehyde thus obtained with a malonic diester having the structural formula (11):
Figure US20020016488A1-20020207-C00017
20. The process as defined by claim 19, carried out according to the following reaction mechanism:
Figure US20020016488A1-20020207-C00018
21. A process for the preparation of a benzalmalonate silane (I) as defined in claim 1 and wherein a is 1, comprising reacting a hydroxybenzalmalonate having the structural formula (12):
Figure US20020016488A1-20020207-C00019
with a halogenated silane having the formula (9):
Hal-Y-SiR1R2R3 (9)
in which Hal is a halogen atom.
22. The process as defined by claim 21, carried out according to the following reaction mechanism:
Figure US20020016488A1-20020207-C00020
US09/332,200 1997-03-07 1999-06-14 UV-photoprotective dibenzoylmethane compositions comprising photostabilizing amounts of benzalmalonate silanes Expired - Fee Related US6426428B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
US09/332,200 US6426428B2 (en) 1997-03-07 1999-06-14 UV-photoprotective dibenzoylmethane compositions comprising photostabilizing amounts of benzalmalonate silanes

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
FR97-02759 1997-03-07
FR9702756 1997-03-07
FR9702759A FR2760464B1 (en) 1997-03-07 1997-03-07 PROCESS FOR IMPROVING THE PHOTOSTABILITY OF A DIBENZOYLMETHANE DERIVATIVE BY SILANE, BENZALMALONATE, PROCESS FOR THE PREPARATION OF BENZALMALONATE SILANES
US09/035,758 US5951968A (en) 1997-03-07 1998-03-06 UV-photoprotective dibenzoylmethane compositions comprising photostabilizing amounts of benzalmalonate silanes
US09/332,200 US6426428B2 (en) 1997-03-07 1999-06-14 UV-photoprotective dibenzoylmethane compositions comprising photostabilizing amounts of benzalmalonate silanes

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
US09/035,758 Division US5951968A (en) 1997-03-07 1998-03-06 UV-photoprotective dibenzoylmethane compositions comprising photostabilizing amounts of benzalmalonate silanes

Publications (2)

Publication Number Publication Date
US20020016488A1 true US20020016488A1 (en) 2002-02-07
US6426428B2 US6426428B2 (en) 2002-07-30

Family

ID=9504530

Family Applications (2)

Application Number Title Priority Date Filing Date
US09/035,758 Expired - Fee Related US5951968A (en) 1997-03-07 1998-03-06 UV-photoprotective dibenzoylmethane compositions comprising photostabilizing amounts of benzalmalonate silanes
US09/332,200 Expired - Fee Related US6426428B2 (en) 1997-03-07 1999-06-14 UV-photoprotective dibenzoylmethane compositions comprising photostabilizing amounts of benzalmalonate silanes

Family Applications Before (1)

Application Number Title Priority Date Filing Date
US09/035,758 Expired - Fee Related US5951968A (en) 1997-03-07 1998-03-06 UV-photoprotective dibenzoylmethane compositions comprising photostabilizing amounts of benzalmalonate silanes

Country Status (4)

Country Link
US (2) US5951968A (en)
EP (1) EP0868905A3 (en)
JP (2) JP2988902B2 (en)
FR (1) FR2760464B1 (en)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050186157A1 (en) * 2004-02-24 2005-08-25 L'oreal Novel silanic para-aminobenzalmalonate-substituted s-triazine compounds and photoprotective compositions comprised thereof
US20100008875A1 (en) * 2007-02-23 2010-01-14 Shiseido Company Ltd. Composition For Skin Or Hair
WO2017037731A1 (en) * 2015-08-29 2017-03-09 Indian Institute Of Technology Bombay Enhanced photostability, extended range uva filtering and camouflaging potential of avobenzone-defect rich zno nanocrystals complex

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2780975B1 (en) 1998-07-10 2002-02-15 Oreal METHOD FOR PHOTOSTABILIZING SUN FILTERS DERIVED FROM DIBENZOYLMETHANE, PHOTOSTABILIZED FILTERING COSMETIC COMPOSITIONS OBTAINED THUS AND THEIR USES
US6071501A (en) * 1999-02-05 2000-06-06 The Procter & Gamble Company Photostable UV protection compositions
US6444195B1 (en) 2001-06-18 2002-09-03 Johnson & Johnson Consumer Companies, Inc. Sunscreen compositions containing a dibenzoylmethane derivative
DE60215656T2 (en) 2001-07-16 2007-08-23 Merck Patent Gmbh PHOTOSTABILE ORGANIC SUN PROTECTION AGENTS WITH ANTIOXIDATIVE PROPERTIES AND COMPOSITIONS THEREWITH
US6602515B2 (en) 2001-07-16 2003-08-05 Em Industries Photo stable organic sunscreen compounds with antioxidant properties and compositions obtained therefrom
US6831191B2 (en) 2001-12-20 2004-12-14 Em Industries Photo stable organic sunscreen compounds with antioxidant properties and compositions obtained therefrom
US6699463B2 (en) 2002-04-10 2004-03-02 Em Industries Photostable cationic organic sunscreen compounds with antioxidant properties and compositions obtained therefrom
JP2005532328A (en) * 2002-05-29 2005-10-27 ユニリーバー・ナームローゼ・ベンノートシヤープ Sunscreen cosmetics stabilized by storage with malonate salt
DE10233963A1 (en) * 2002-07-25 2004-02-12 Itn-Nanovation Gmbh Use of silanes in cosmetic products and methods for hair treatment
US6936735B2 (en) * 2002-08-27 2005-08-30 Emd Chemicals, Inc. Photostable cationic organic sunscreen compounds and compositions obtained therefrom
FR2850382B1 (en) * 2003-01-28 2007-12-28 CINNAMATE, CINNAMAMIDE, BENZALMALONAMIDE OR BENZALMALONATE-BASED METHYLTRIALKYLSILANES PHOTOPROTECTIVE COMPOSITIONS
EP1594880B1 (en) 2003-01-28 2008-03-19 L'oreal Photoprotective compositions based on methyltrialkylsilanes containing a cinnamate, cinnamamide, benzalmalonamide or benzalmalonate function
US20040185015A1 (en) * 2003-03-17 2004-09-23 Unilever Home & Personal Care Usa, Division Of Conopco, Inc. Sunscreen cosmetic compositions storage stabilized with malonate salts
GB0501365D0 (en) * 2005-01-21 2005-03-02 Promar As Compositions
FR2886144B1 (en) * 2005-05-27 2007-06-29 Oreal METHOD FOR PHOTOSTABILIZING A DIBENZOYLMETHANE DERIVATIVE WITH A MEROCYANINE SULFONE DERIVATIVE; PHOTOPROTECTIVE COSMETIC COMPOSITIONS CONTAINING THE SAME.
JP4691464B2 (en) * 2006-03-28 2011-06-01 株式会社資生堂 Skin or hair composition
US20080286217A1 (en) * 2007-05-14 2008-11-20 Chaudhuri Ratan K Sunscreen compositions and methods
US9095510B2 (en) 2009-11-10 2015-08-04 Laboratory Skin Care, Inc. Sunscreen compositions comprising uniform, rigid, spherical, nanoporous calcium phosphate particles and methods of making and using the same
US8617528B2 (en) 2010-12-06 2013-12-31 Sytheon Ltd. Compositions and methods for stabilizing ingredients using 2,4-pentanedione compounds
JP5955583B2 (en) * 2012-02-24 2016-07-20 株式会社Adeka Novel compounds, dyes and colored photosensitive compositions
KR20190082254A (en) 2016-10-31 2019-07-09 시테온 리미티드 Composition and method for skin improvement
US11510885B2 (en) 2019-12-02 2022-11-29 Sytheon Ltd. Compositions and methods for regulating the endocannabinoid system

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2642967B1 (en) * 1989-02-15 1991-06-07 Oreal COSMETIC USE OF BENZALMALONATE FUNCTIONAL DIORGANOPOLYSILOXANES AND NOVEL COSMETIC COMPOSITIONS CONTAINING THESE COMPOUNDS FOR PROTECTION OF THE SKIN AND HAIR
US5536732A (en) * 1990-04-27 1996-07-16 Merrell Pharmaceuticals Inc. N-derivatives of 1-deoxy nojirimycin
FR2674850B1 (en) * 1991-04-04 1993-07-02 Oreal S-TRIAZINIC DERIVATIVES CARRYING BENZALMALONATE SUBSTITUTES, FILTERING COSMETIC COMPOSITIONS CONTAINING THEM AND THEIR USE FOR PROTECTING THE SKIN AND HAIR FROM ULTRAVIOLET RADIATION.
FR2680684B1 (en) * 1991-08-29 1993-11-12 Oreal COSMETIC FILTERING COMPOSITION COMPRISING A METAL OXIDE NANOPIGMENT AND A FILTERED POLYMER.
JP3447804B2 (en) * 1994-06-10 2003-09-16 花王株式会社 Benzal malonate derivative having organosilicon group, method for producing the same, ultraviolet absorber and cosmetic containing the same
ATE212536T1 (en) * 1994-10-14 2002-02-15 Hoffmann La Roche LIGHT STABLE COSMETIC SUNSCREEN PRODUCTS
FR2727113B1 (en) * 1994-11-17 1996-12-27 Oreal NOVEL SOLAR FILTERS, PHOTOPROTECTIVE COSMETIC COMPOSITIONS CONTAINING THEM AND USES THEREOF
FR2727861B1 (en) * 1994-12-12 1997-01-17 Oreal PROCESS FOR THE PHOTOSTABILIZATION OF DIBENZOYLMETHANE-DERIVED SOLAR FILTERS, PHOTOSTABILIZED FILTERING COSMETIC COMPOSITIONS THUS OBTAINED AND THEIR USES
FR2744721B1 (en) * 1996-02-12 1999-06-18 Oreal NOVEL INSOLUBLE S-TRIAZINE DERIVATIVES, PROCESS FOR THEIR PREPARATION, COMPOSITIONS CONTAINING THEM AND USES THEREOF

Cited By (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050186157A1 (en) * 2004-02-24 2005-08-25 L'oreal Novel silanic para-aminobenzalmalonate-substituted s-triazine compounds and photoprotective compositions comprised thereof
US8221728B2 (en) * 2004-02-24 2012-07-17 L'oreal Silanic para-aminobenzalmalonate-substituted s-triazine compounds and photoprotective compositions comprised thereof
US8221730B2 (en) 2004-02-24 2012-07-17 L'oreal Silanic para-aminobenzalmalonate-substituted s-triazine compounds and photoprotective compositions comprised thereof
US20100008875A1 (en) * 2007-02-23 2010-01-14 Shiseido Company Ltd. Composition For Skin Or Hair
US8282910B2 (en) 2007-02-23 2012-10-09 Shiseido Company Ltd. Composition for skin or hair
WO2017037731A1 (en) * 2015-08-29 2017-03-09 Indian Institute Of Technology Bombay Enhanced photostability, extended range uva filtering and camouflaging potential of avobenzone-defect rich zno nanocrystals complex

Also Published As

Publication number Publication date
US5951968A (en) 1999-09-14
JP2000136120A (en) 2000-05-16
FR2760464A1 (en) 1998-09-11
FR2760464B1 (en) 2005-07-01
JP2988902B2 (en) 1999-12-13
US6426428B2 (en) 2002-07-30
EP0868905A3 (en) 2006-10-18
JP3027158B1 (en) 2000-03-27
EP0868905A2 (en) 1998-10-07
JPH10324620A (en) 1998-12-08

Similar Documents

Publication Publication Date Title
US5951968A (en) UV-photoprotective dibenzoylmethane compositions comprising photostabilizing amounts of benzalmalonate silanes
AU666454B2 (en) Antisun cosmetic compositions and uses
AU756928B2 (en) Method for improving UV radiation stability of photosensitive sunscreen filters
US5882633A (en) Compositions comprising a dibenzoylmethane derivative, a 1,3,5-triazine derivative and an amide compound, and methods of use therefor
AU677119B2 (en) Photoprotective cosmetic compositions and uses
US5605678A (en) Photoprotective/cosmetic compositions comprising 2,4,6-tris[p-((2'-ethylhexyl)oxycarbonyl)anilino]-1,3,5-triazine andoily esters
US5928629A (en) Photoprotective/cosmetic compositions comprising dibenzoylmethane/triazine/diphenylacrylate compounds
US5882632A (en) Compositions comprising a dibenzoylmethane derivative, a 1,3,5-triazine derivative and a silicon derivative containing a benzalmalonate function, and methods of use therefor
US5753209A (en) Photoprotective/cosmetic compositions comprising synergistic admixture of sunscreen compounds
US5882634A (en) Compositions comprising a dibenzoylmethane derivative, a 1,3,5-triazine derivative and a dialkyl benzalmalonate, and methods of use therefor
US6071502A (en) Photostable sunscreen compositions comprising dibenzoylmethane compounds and 2-hydroxybenzophenone-substituted silanes/organosiloxanes
US6143282A (en) Photoprotective/cosmetic compositions comprising benzotriazole-substituted silicon sunscreens and cinnamic/salicylic acid solubilizing agents therefor
US6312673B2 (en) Photostabilized sunscreen compositions comprising dibenzoylmethane compounds and benzylidenecamphor-substituted silanes/organosiloxanes
US6030629A (en) Photoprotective cosmetic/dermatological compositions comprising synergistic admixture of sunscreen compounds
US6569409B1 (en) Method for providing dibenzoylmethane derivatives with light stability
AU740339B2 (en) Process for the photostabilization of sunscreens derived from dibenzoylmethane by an insoluble organic screening agent
US6114559A (en) Silicone-substituted cinnamamide/malonamide/malonate compounds and photoprotective compositions comprised thereof
US5955061A (en) Cosmetic filter compositions containing dibenzoylmethane, alkyl β, β'-diphenylacrylate and benzotriazole silicone, and uses thereof
US6080880A (en) Silicone-substituted cinnamamide/malonamide/malonate compounds and photoprotective compositions comprised thereof
US6776980B1 (en) Photoprotective/cosmetic compositions comprising dibenzoylmethane/triazine/diphenylacrylate compounds
US20040037791A1 (en) Photoprotective UV-screening compositions comprising (phenylsulfonyl) acrylonitrile-substituted silanes/siloxanes
MXPA01005460A (en) Method for improving uv radiation stability of photosensitive sunscreen filters

Legal Events

Date Code Title Description
FPAY Fee payment

Year of fee payment: 4

REMI Maintenance fee reminder mailed
LAPS Lapse for failure to pay maintenance fees
STCH Information on status: patent discontinuation

Free format text: PATENT EXPIRED DUE TO NONPAYMENT OF MAINTENANCE FEES UNDER 37 CFR 1.362

FP Lapsed due to failure to pay maintenance fee

Effective date: 20100730